지씨셀

144510KOSDAQ

42.5 / 100

Reference Date: 2026-10-23

Financial Score16.0 / 40

News Sentiment12.5 / 25

Momentum4.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Slightly down 4.2% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

GC Cell is a company primarily engaged in the development and commercialization of cell therapies, specimen testing, cord blood banking, bio-logging, and CDMO services. The company is focusing on the development of NK and T cell therapies and is advancing research on next-generation CAR-NK and CAR-T treatments.

Number of Employees

806people

Average Salary

48.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

1.12Industry Average 1.204.0Point

In line with industry avg

ROE

-83.81Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

18.04Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20250.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼6.1% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼279.8% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -33.0% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (5%, downtrend)

Current 13,520Won52-week high 27,50052-week low 12,710

1-month return2.0Point

1m -4.18% (slight drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0